Clinical Trial Update: Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating reduced-intensity, related-donor bone marrow transplantation followed by high-dose cyclophosphamide for hematologic cancers. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Myelodysplastic Syndrome

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Lymphoma, Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2018-07-03